38/120
1.6 / 5 stars
All 120 Win/Lose results shown below
FLGT Roast Me summary
Fulgent Genetics, Inc. (FLGT). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
Trailing 1 year (4 quarters): 5 wins, 7 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinFLGT / S&P 29.06% / 15.20% |
LoseFLGT / S&P 6.83% / 15.00% |
LoseFLGT / S&P FLGT unavailable / 50.40% |
| 2026-Q10/3 |
LoseFLGT / S&P -39.47% / -4.33% |
LoseFLGT / S&P 9.54% / 11.30% |
LoseFLGT / S&P FLGT unavailable / 27.70% |
| 2025-Q42/3 |
WinFLGT / S&P 16.24% / 2.65% |
WinFLGT / S&P 13.83% / 9.00% |
LoseFLGT / S&P FLGT unavailable / 13.40% |
| 2025-Q32/3 |
WinFLGT / S&P 13.68% / 8.12% |
WinFLGT / S&P 13.60% / 4.61% |
LoseFLGT / S&P FLGT unavailable / 13.45% |
| 2025-Q21/3 |
WinFLGT / S&P 17.63% / 10.94% |
LoseFLGT / S&P 4.31% / 4.83% |
LoseFLGT / S&P FLGT unavailable / 10.63% |
| 2025-Q10/3 |
LoseFLGT / S&P -8.50% / -4.27% |
LoseFLGT / S&P 1.71% / 4.98% |
LoseFLGT / S&P FLGT unavailable / 10.57% |
| 2024-Q40/3 |
LoseFLGT / S&P -15.00% / 2.41% |
LoseFLGT / S&P -1.99% / 5.25% |
LoseFLGT / S&P FLGT unavailable / 6.15% |
| 2024-Q31/3 |
WinFLGT / S&P 10.75% / 5.89% |
LoseFLGT / S&P -3.02% / 5.89% |
LoseFLGT / S&P FLGT unavailable / 6.11% |
| 2024-Q20/3 |
LoseFLGT / S&P -9.59% / 4.28% |
LoseFLGT / S&P -5.42% / 5.38% |
LoseFLGT / S&P FLGT unavailable / 5.12% |
| 2024-Q10/3 |
LoseFLGT / S&P -24.94% / 10.56% |
LoseFLGT / S&P -21.20% / 5.71% |
LoseFLGT / S&P FLGT unavailable / 5.59% |
| 2023-Q40/3 |
LoseFLGT / S&P 8.12% / 11.69% |
LoseFLGT / S&P -53.27% / 6.81% |
LoseFLGT / S&P FLGT unavailable / 7.78% |
| 2023-Q30/3 |
LoseFLGT / S&P -27.79% / -3.27% |
LoseFLGT / S&P -64.33% / 7.52% |
LoseFLGT / S&P FLGT unavailable / -5.03% |
| 2023-Q21/3 |
WinFLGT / S&P 18.61% / 8.74% |
LoseFLGT / S&P -66.78% / 9.50% |
LoseFLGT / S&P FLGT unavailable / -8.57% |
| 2023-Q10/3 |
LoseFLGT / S&P 4.84% / 7.50% |
LoseFLGT / S&P -61.73% / 10.77% |
LoseFLGT / S&P FLGT unavailable / -15.69% |
| 2022-Q40/3 |
LoseFLGT / S&P -21.88% / 7.56% |
LoseFLGT / S&P -37.64% / 11.88% |
LoseFLGT / S&P FLGT unavailable / -17.99% |
| 2022-Q30/3 |
LoseFLGT / S&P -30.09% / -4.88% |
LoseFLGT / S&P -22.49% / 13.47% |
LoseFLGT / S&P FLGT unavailable / -1.41% |
| 2022-Q21/3 |
WinFLGT / S&P -12.63% / -16.10% |
LoseFLGT / S&P 1.69% / 13.71% |
LoseFLGT / S&P FLGT unavailable / 11.04% |
| 2022-Q11/3 |
LoseFLGT / S&P -37.96% / -4.60% |
WinFLGT / S&P 23.28% / 15.97% |
LoseFLGT / S&P FLGT unavailable / 42.23% |
| 2021-Q42/3 |
WinFLGT / S&P 11.83% / 11.03% |
WinFLGT / S&P 135.37% / 15.00% |
LoseFLGT / S&P FLGT unavailable / 96.40% |
| 2021-Q31/3 |
LoseFLGT / S&P -2.47% / 0.58% |
WinFLGT / S&P 666.64% / 10.77% |
LoseFLGT / S&P FLGT unavailable / 69.42% |
| 2021-Q21/3 |
LoseFLGT / S&P -4.54% / 8.55% |
WinFLGT / S&P 1979.31% / 6.58% |
LoseFLGT / S&P FLGT unavailable / 51.81% |
| 2021-Q12/3 |
WinFLGT / S&P 85.45% / 6.17% |
WinFLGT / S&P 2115.31% / -1.06% |
LoseFLGT / S&P FLGT unavailable / 7.39% |
| 2020-Q42/3 |
WinFLGT / S&P 30.12% / 12.15% |
WinFLGT / S&P 1196.46% / -3.72% |
LoseFLGT / S&P FLGT unavailable / -33.42% |
| 2020-Q32/3 |
WinFLGT / S&P 150.25% / 8.93% |
WinFLGT / S&P 353.21% / -2.04% |
LoseFLGT / S&P FLGT unavailable / -27.10% |
| 2020-Q22/3 |
WinFLGT / S&P 48.70% / 20.54% |
WinFLGT / S&P 74.37% / -0.46% |
LoseFLGT / S&P FLGT unavailable / -27.11% |
| 2020-Q12/3 |
WinFLGT / S&P -16.59% / -19.60% |
WinFLGT / S&P 58.20% / 3.47% |
LoseFLGT / S&P FLGT unavailable / -14.75% |
| 2019-Q42/3 |
WinFLGT / S&P 24.16% / 9.07% |
WinFLGT / S&P 52.35% / 5.36% |
LoseFLGT / S&P FLGT unavailable / 2.99% |
| 2019-Q32/3 |
WinFLGT / S&P 55.54% / 1.70% |
WinFLGT / S&P 49.38% / 5.02% |
LoseFLGT / S&P FLGT unavailable / 0.21% |
| 2019-Q22/3 |
WinFLGT / S&P 12.27% / 4.30% |
WinFLGT / S&P 33.21% / 6.64% |
LoseFLGT / S&P FLGT unavailable / 8.65% |
| 2019-Q12/3 |
WinFLGT / S&P 87.70% / 13.65% |
WinFLGT / S&P 22.08% / 8.12% |
LoseFLGT / S&P FLGT unavailable / 14.29% |
| 2018-Q41/3 |
LoseFLGT / S&P -19.34% / -13.52% |
WinFLGT / S&P 13.99% / 9.05% |
LoseFLGT / S&P FLGT unavailable / 18.23% |
| 2018-Q30/3 |
LoseFLGT / S&P -5.07% / 7.71% |
LoseFLGT / S&P -1.69% / 10.21% |
LoseFLGT / S&P FLGT unavailable / 19.06% |
| 2018-Q21/3 |
WinFLGT / S&P 3.50% / 3.43% |
LoseFLGT / S&P -9.49% / 9.03% |
LoseFLGT / S&P FLGT unavailable / 14.46% |
| 2018-Q10/3 |
LoseFLGT / S&P -8.68% / -0.76% |
LoseFLGT / S&P -10.25% / 7.68% |
LoseFLGT / S&P FLGT unavailable / 12.46% |
| 2017-Q40/3 |
LoseFLGT / S&P -8.56% / 6.64% |
LoseFLGT / S&P 2.48% / 7.03% |
LoseFLGT / S&P FLGT unavailable / 13.82% |
| 2017-Q31/3 |
LoseFLGT / S&P -25.04% / 4.48% |
WinFLGT / S&P 32.50% / 5.68% |
LoseFLGT / S&P FLGT unavailable / 17.57% |
| 2017-Q21/3 |
LoseFLGT / S&P -41.48% / 3.09% |
WinFLGT / S&P 57.46% / 4.83% |
LoseFLGT / S&P FLGT unavailable / 17.74% |
| 2017-Q10/3 |
LoseFLGT / S&P -5.62% / 6.07% |
LoseFLGT / S&P FLGT unavailable / 3.67% |
LoseFLGT / S&P FLGT unavailable / 13.32% |
| 2016-Q42/3 |
WinFLGT / S&P 25.49% / 3.82% |
WinFLGT / S&P 90.85% / 2.09% |
LoseFLGT / S&P FLGT unavailable / 7.05% |
| 2016-Q30/3 |
LoseFLGT / S&P FLGT unavailable / 3.85% |
LoseFLGT / S&P FLGT unavailable / 0.20% |
LoseFLGT / S&P FLGT unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | FLGT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -11.46% | 20.78% |
| Annualized return | -11.46% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | FLGT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -78.75% | 83.14% |
| Annualized return | -26.64% | 12.86% |
10Y · 2016-09-29 to 2026-08-28
| Metric | FLGT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 113.83% | 319.30% |
| Annualized return | 7.90% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |